North American prostate cancer diagnostics and therapeutics market is expected to grow at a CAGR of 10.4% during the forecast period. The major factors for the growth of the market include the high prevalence of prostate cancer in the region which raises the demand for efficient diagnostics and therapies for the treatment of cancer. As per World Health Organization, in the North America, prostate cancer is the most prevalent cancer among men. Around 234,000 new cases of prostate cancer has been registered in 2018 in the region. Additionally, in 2018, around 18.5% of the total cases of cancer are related to prostate cancer in the US. Moreover, the adoption of innovative technologies for the diagnosis of prostate cancer such as biomarkers and the adoption of personalized medicine for treatment is expected to fuel the market.

Request a free sample of our report on North American Prostate Cancer Diagnostics and Therapeutics https://www.omrglobal.com/request-sample/north-american-prostate-cancer-diagnostic-therapeutic-market

North American prostate cancer diagnostic market is divided on the basis of diagnostic technique and therapeutics. By diagnostic technique, the market is segmented into prostate-specific antigen test, digital rectal examination, prostate biopsy, imaging techniques. Prostate biopsy is expected to hold a major market share during the forecast period. By therapeutics, the market is segmented into hormonal therapy, chemotherapy, immunotherapy, radiation therapy, targeted therapy, surgery. During the forecast period, chemotherapy is expected to have a major market share in the region. Geographically, the market is divided into the US and Canada. The US is expected to hold the major major market share during the forecast period.

A full Report of North American Prostate Cancer Diagnostics and Therapeutics is Available at: https://www.omrglobal.com/industry-reports/north-american-prostate-cancer-diagnostic-therapeutic-market

The companies which are contributing significantly in the market include Abbott Laboratories, AbbVie Products, LLC, Amgen Inc., Ferring Pharmaceuticals Inc., Johnson & Johnson, Siemens Healthineers AG, Amgen Inc., AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Co., GlaxoSmithKline PLC, Johnson & Johnson, Pfizer Inc., Siemens Healthineers AG, and others. The market players are considerably contributing to the market growth by the adoption of various growth strategies including new product launch, merger, and acquisition, collaborations with government, and technological advancements to stay competitive in the market.

North American Prostate Cancer Diagnostics and Therapeutics Segmentation

By Diagnostic Techniques

• Prostate-Specific Antigen Test (PSA)
• Digital Rectal Examination
• Prostate Biopsy
• Imaging Techniques

By Therapeutics

• Hormonal Therapy
• Chemotherapy
• Immunotherapy
• Radiation Therapy
• Targeted Therapy
• Surgery



Regional Analysis

• United States
• Canada

Company Profiles

• Abbott Laboratories
• AbbVie Products, LLC
• Amgen Inc.
• AstraZeneca PLC
• Bavarian Nordic A/S
• Bayer AG
• Bristol-Myers Squibb Co.
• Endo Pharmaceuticals Inc.
• Ferring Pharmaceuticals Inc.
• GlaxoSmithKline PLC
• Johnson & Johnson
• Pfizer Inc.
• Siemens Healthcare AG
• Decipher Biosciences, Inc.
• Nanostics Inc.

For More Customized Data, Request for Report Customization https://www.omrglobal.com/report-customization/north-american-prostate-cancer-diagnostic-therapeutic-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. AnuragTiwari
Email: [email protected]
Contact no: +1 646-755-7667, +91 780-304-0404